Stent Versus Conservative Treatment in Patients With Deep Venous Obstruction

A Randomized Controlled Trial Comparing Venous Stenting With Conservative Treatment in Patients With Deep Venous Obstruction

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03026049

Acronym

STEVECO

Enrollment

Registered

2017-01-20

Start date

2017-03-09

Completion date

2021-10-07

Last updated

2022-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep Venous Stenting, Deep-Venous Thrombosis, Randomized Clinical Trial

Brief summary

Patients will be randomised between deep venous stenting or conservative management

Interventions

DEVICEdeep venous stenting

Deep venous stent

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age \>18 years * Meet criteria for PTS or * Patients with May Thurner syndrome on additional imaging * Life expectancy of more than one year * Deep venous thrombosis \> 1 year * Signed informed consent

Exclusion criteria

* Previous intervention of central veins (inferior vena cava, iliac veins, common femoral vein) on the affected limb * Known pregnancy * Inability to answer Dutch QoL questionnaires or limited communication in Dutch (written and spoken) * Contra-indication for prolonged anticoagulant treatment * Recent, \<1 year, deep venous thrombosis or pulmonary Embolism * Known contrast allergy * Known dialysis or renal insufficiency needing additional preparation for injection of contrast

Design outcomes

Primary

Measure	Time frame	Description
Quality of Life score	12 months	Quality of Life score

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026